Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).

Adv Ther · 2018 · PMC6224005 · PMID 30232708

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

close to significanceno p-value reported

Because the results for age, gender, and multifocality were close to significance, further tests of these variables were also included in the Kaplan–Meier survival analysis.

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.